121 related articles for article (PubMed ID: 37302026)
1. The prognostic significance of DDIT4 in endometrial cancer.
Yoshikawa N; Yoshida K; Liu W; Matsukawa T; Hattori S; Yoshihara M; Tamauchi S; Ikeda Y; Yokoi A; Shimizu Y; Niimi K; Kajiyama H
Cancer Biomark; 2023; 37(4):217-225. PubMed ID: 37302026
[TBL] [Abstract][Full Text] [Related]
2. Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer.
Chen X; Li Z; Liang M; Zhang Z; Zhu D; Lin B; Zhou R; Lu Y
World J Surg Oncol; 2023 Jun; 21(1):194. PubMed ID: 37391802
[TBL] [Abstract][Full Text] [Related]
3. DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma.
Song L; Chen Z; Zhang M; Zhang M; Lu X; Li C; Miao L
J Cancer; 2021; 12(21):6422-6428. PubMed ID: 34659532
[No Abstract] [Full Text] [Related]
4. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Acs G; Xu X; Chu C; Acs P; Verma A
Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
[TBL] [Abstract][Full Text] [Related]
5. High expression of DNA damage-inducible transcript 4 (DDIT4) is associated with advanced pathological features in the patients with colorectal cancer.
Fattahi F; Saeednejad Zanjani L; Habibi Shams Z; Kiani J; Mehrazma M; Najafi M; Madjd Z
Sci Rep; 2021 Jul; 11(1):13626. PubMed ID: 34211002
[TBL] [Abstract][Full Text] [Related]
6. In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies.
Pinto JA; Rolfo C; Raez LE; Prado A; Araujo JM; Bravo L; Fajardo W; Morante ZD; Aguilar A; Neciosup SP; Mas LA; Bretel D; Balko JM; Gomez HL
Sci Rep; 2017 May; 7(1):1526. PubMed ID: 28484222
[TBL] [Abstract][Full Text] [Related]
7. The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma.
Foltyn M; Luger AL; Lorenz NI; Sauer B; Mittelbronn M; Harter PN; Steinbach JP; Ronellenfitsch MW
Br J Cancer; 2019 Mar; 120(5):481-487. PubMed ID: 30745581
[TBL] [Abstract][Full Text] [Related]
8. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer.
Song H; Li C; Lu R; Zhang Y; Geng J
Int J Gynecol Cancer; 2010 Oct; 20(7):1188-96. PubMed ID: 21495225
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of DDIT4 predicts poor prognosis in acute myeloid leukaemia.
Cheng Z; Dai Y; Pang Y; Jiao Y; Liu Y; Cui L; Quan L; Qian T; Zeng T; Si C; Huang W; Chen J; Pang Y; Ye X; Shi J; Fu L
J Cell Mol Med; 2020 Jan; 24(1):1067-1075. PubMed ID: 31755224
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer.
Ong CHC; Lee DY; Lee B; Li H; Lim JCT; Lim JX; Yeong JPS; Lau HY; Thike AA; Tan PH; Iqbal J
Breast Cancer Res; 2022 Jun; 24(1):38. PubMed ID: 35659359
[TBL] [Abstract][Full Text] [Related]
11. Construction of novel hypoxia-related gene model for prognosis and tumor microenvironment in endometrial carcinoma.
Chen J; Wang G; Zhang D; Luo X; Zhang D; Zhang Y
Front Endocrinol (Lausanne); 2022; 13():1075431. PubMed ID: 36589842
[TBL] [Abstract][Full Text] [Related]
12. BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor.
Yu J; Chen L; Bao Z; Liu Y; Liu G; Li F; Li L
Oncol Rep; 2020 May; 43(5):1630-1640. PubMed ID: 32323819
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of hypoxia-inducible factor 1α, TWIST and E-cadherin is associated with aggressive tumor phenotypes in endometrioid endometrial carcinoma.
Feng Z; Gan H; Cai Z; Li N; Yang Z; Lu G; Chen J
Jpn J Clin Oncol; 2013 Apr; 43(4):396-403. PubMed ID: 23372184
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data.
Koh YW; Lee SJ; Han JH; Haam S; Jung J; Lee HW
Lung Cancer; 2019 Mar; 129():41-47. PubMed ID: 30797490
[TBL] [Abstract][Full Text] [Related]
15. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer.
Yabushita H; Shimazu M; Yamada H; Sawaguchi K; Noguchi M; Nakanishi M; Kawai M
Gynecol Oncol; 2001 Feb; 80(2):139-44. PubMed ID: 11161851
[TBL] [Abstract][Full Text] [Related]
16. Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.
Seeber LM; Horrée N; van der Groep P; van der Wall E; Verheijen RH; van Diest PJ
BMC Cancer; 2010 Jun; 10():307. PubMed ID: 20565904
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia contributes to development of recurrent endometrial carcinoma.
Pijnenborg JM; Wijnakker M; Hagelstein J; Delvoux B; Groothuis PG
Int J Gynecol Cancer; 2007; 17(4):897-904. PubMed ID: 17359291
[TBL] [Abstract][Full Text] [Related]
18. Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.
Watari H; Xiong Y; Hassan MK; Sakuragi N
Gynecol Oncol; 2009 Jan; 112(1):229-34. PubMed ID: 19007976
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer].
Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
[No Abstract] [Full Text] [Related]
20. Prognostic significance of Bcl-2, p53 overexpression, and lymph node metastasis in surgically staged endometrial carcinoma.
Ohkouchi T; Sakuragi N; Watari H; Nomura E; Todo Y; Yamada H; Fujimoto S
Am J Obstet Gynecol; 2002 Aug; 187(2):353-9. PubMed ID: 12193924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]